(Brief overview and report on – UWTI, UGLD,PMCB and NHMD- see below)
NOTE*** Starting today at 9:30 AM and this week we are featuring (OTCBB: MMPW) to our members. Analyst report MMPW- https://broadstreetalerts.com/wp-content/uploads/2016/02/MMPW-Analyst-Target-1.pdf
About Broad Street Alerts:
Big opportunities in Small Cap’s in a down market
Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.
December 29th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.
December 15th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.
December 2nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
Full Reports
Brief Report for Nate’s Food Co. (OTCBB: NHMD)
Effective in January, Jeff West, who has been working with the Company for the past year as a senior consultant and who has now agreed to accept the newly created position of Director of Sales Operations for both domestic and international retail sales. Jeff has a BA in psychology and an MBA in business administration, both awarded by the University of California, Irvine. Jeff has owned his own company since 2006, and he has been working in global sales, marketing, business development and product distribution since 2000. Jeff is currently representing the Company in talks with a broad range of grocery retailers including Kroeger Stores, Costco, Sam’s Club and Walmart, as well as other stores throughout America and in several overseas markets.
Product
Nate’s Homemade sells a ready-to-use, pre-mixed pancake and waffle batter delivered in a pressurized can. The Company is currently developing additional flavors and products with the goal to have 10 products in development in 2015. Currently, the Company is developing 3 flavors for its pancake and waffle mix and a One-Minute Omelet and Guacamole. The Company will continue to expand into other bake goods and other non-breakfast areas. The license agreement is for a term of twenty (20) years. The Company has the right to renew the license agreement for successive ten (10) year period by paying $1,000,000 for each new term.
Payments/Royalty
The Company shall pay a royalty equal to three percent (3%) of the gross revenue from the licensed products. Gross revenue is defined as total revenue minus discounts and allowances. The license requires that the Company pay a minimum monthly fee of $5,500 beginning twelve (12) months from the execution of the license agreement which is against the 3% royalty.
Buy-Out
The Company also has the option, at its election, to the purchase the intellectual property associated to the license agreement. The buy-out amount is equal to revenue for the 12 months immediately prior to the buy-out.
Brief Report for PharmaCyte Biotech, Inc. (OTCQB: PMCB)
About PharmaCyte Biotech
PharmaCyte’s treatment for cancer involves encapsulating “Cell-in-a-Box®” genetically modified live cells that convert an inactive chemotherapy drug (ifosfamide) into its active or “cancer-killing” form. These encapsulated live cells are placed as close to a cancerous tumor as possible. Once implanted in a patient, a chemotherapy drug which needs to be activated in the body (prodrug) is then given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been placed. When ifosfamide, which is normally activated in the liver, comes in contact with the encapsulated live cells, activation of the chemotherapy drug takes place at the source of the cancer without any side effects from the chemotherapy.
PharmaCyte’s treatment for type 1 diabetes and type 2 insulin-dependent diabetes is an encapsulated human cell line, called the Melligen cell line, which are liver cells that have been genetically modified to produce, store and release insulin in response to blood glucose levels in their surroundings. PharmaCyte will encapsulate the Melligen cells using its signature live-cell encapsulation technology, Cell-in-a-Box®.
Stonegate Capital Partners, a privately held corporate advisory firm that receives payments from PMCB, issued a Research Report featuring PharmaCyte Biotech. The report is comprehensive and details the PMCB technological platform. The report can be viewed at http://stonegateinc.com/reports/Pharma_Feb_2016.pdf
Brief Report for VelocityShares 3x Long Crude Oil ETN (AMEX: UWTI)
Category: Trading-Leveraged Commodities
Fund Family: Credit Suisse AG
Net Assets: 832.22M
Yield: 0.00%
Fund Inception Date: Feb 7, 2012
Legal Type: Exchange Traded Fund
Excerpted From:
Market Realist
By Gordon Kristopher
February 11, 2016 9:26 AM
US crude oil refinery demand
The EIA (U.S. Energy Information Administration) released its “This Week in Petroleum” report on February 10, 2016. It reported that the US crude oil refinery demand fell by 105,000 bpd (barrels per day) to 15.5 MMbpd (million barrels per day) for the week ending February 5, 2016. Last week, the US crude oil refinery demand fell by 24,000 bpd for the week ending January 29, 2016. US refineries operated at 86.1% operable capacity for the week ending February 5, 2016—compared to 86.6% for the week ending January 29, 2016.
US refinery demand by region
The US refinery demand rose to 8 MMbpd in the Gulf Coast region for the week ending February 5, 2016. In contrast, the US crude oil refinery demand fell in the Midwest and West Coast regions for the same period. These three regions contribute to most of the US crude oil refinery demand.
US crude oil refinery demand in 2015
Currently, the US crude oil refinery demand is 0.6% less than the refinery demand of 15.56 MMbpd last year. The fall in refinery demand is due to record gasoline and distillate stocks. The weak refinery demand will lead to a rise in crude oil stocks. It will have a negative impact on crude oil prices. The fall in crude oil prices impacts oil producers like Devon Energy (DVN), Energen (EGN), Laredo Petroleum (LPI), and Pioneer Natural Resources (PXD). The fall in refinery demand also suggests weak retail demand. It impacts refiners such as Valero Energy (VLO), HollyFrontier (HFC), Marathon Oil (MPC), and Phillips 66 (PSX).
The EIA (U.S. Energy Information Administration) released its Short-Term Energy Outlook report on February 9, 2016. The report forecast that Brent crude oil prices could average $38 per barrel in 2016 and $50 per barrel in 2017. US benchmark West Texas Intermediate crude oil prices could average $38 per barrel in 2016 and $50 per barrel in 2017. The World Bank estimates that crude oil prices will trade around $37 per barrel in 2016. Morgan Stanley estimates that the consensus of the appreciating dollar will put pressure on oil prices. A 5% appreciation in the US dollar could cause a 10%–25% fall in crude oil prices in 2016. Standard Chartered estimates that oil prices could hit $10 per barrel in the worst-case scenario in 2016.
Brief Report for VelocityShares 3x Long Gold ETN (NYSEArca: UGLD)
Category: Trading-Leveraged Commodities
Fund Family: Credit Suisse AG
Net Assets: 60.80M
Yield: 0.00%
Fund Inception Date: Oct 14, 2011
Legal Type: Exchange Traded Fund
Excerpted from:
Zacks
By Sweta Killa
January 21, 2016 8:48 AM
Gold regained its sheen at the start of the year with investors shunning risky assets in favor of safe havens. This is especially true in the backdrop of the persistent slump in crude oil prices, the China rout and the continued bearishness in the stock market – conditions that are raising the safe haven appeal across the board.
In fact, gold bullion has gained nearly 4% in the year-to-date time frame and is easily outperforming the broad markets when compared to the losses of 9% for the S&P 500, 10.7% for NASDAQ, 9.5% for Dow Jones. Gold is trading above $1,100 per ounce at the time of writing with some forecasting bigger gains in the days ahead (read: Market Stings? 6 Techniques for a Winning ETF Portfolio).
Global Uncertainty on Rise
The start of 2016 stirred up more chaos across the globe, intensifying fears of a global slowdown. China is not the only region to worry as other emerging markets like Brazil and Russia are also on the verge of collapse while a debt-laden Eurozone, recession in Japan and renewed tension in the Middle East are adding to the long list of woes.
Further, the recent slew of weak U.S. economic data including sluggish manufacturing numbers, weak retail sales data, weak consumer-price data, and disappointing housing data, reflects that the global slowdown has started to hurt the slowly recovering U.S. economy, making investors’ jittery. Apart from these, gold will likely get boost from the delay in the next rate hike, which now seems unlikely in March. If this happens, demand for gold will get a solid boost.
DISCLAIMER
Broad Street Alerts has compensated the author of this report (LIX Research Group) up to two hundred and fifty dollars for the redistribution rights for a period of up to 30 days.
BroadStreetAlerts.com is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC. SCS LLC has not been compensated for the mention of UWTI, UGLD, PMCB or NHMD. We were previously compensated up to ninety thousand dollars for the mention of INVT and XXII however those contracts have since expired. SCS LLC has been compensated fifteen thousand dollars by Cream Consulting, LLC for a two day investor relations program of MMPW starting 2/26/16.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We have not been compensated in any form by any entity for this report. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold SCS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.
SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. SCS LLC is not a Broker/Dealer and does not engage in high frequency trading.
